spacer
home > pmps > spring 2017 > new thinking
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Thinking

When it comes to complacency, Albert Einstein once remarked: “If you always do what you always did, you will always get what you always got.” This very principle applies in healthcare and for today’s seven billion global consumers, who are living longer, have better access to quality care and are demanding more choices, greater convenience and improved outcomes.

It is an evolving paradigm, and delivering sophisticated, high-value pharmaceuticals to emerging markets will require continuous new thinking. The same supply chain issues will continue to pose steady challenges – cost and compliance chief among them – but leveraging cold chain innovations will produce significant gains in years to come.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jan Denecker is responsible for executing UPS’s healthcare strategy in Europe. He joined the company in 2011 as Marketing Manager of Healthcare and led the launch of the department in Europe. In 2014, Jan was appointed Marketing Manager of Belgium and Luxembourg, responsible for business planning, revenue management, marketing and communications in both countries. He holds a Master’s degree in Law from the Université catholique de Louvain, Belgium, and a Master’s degree in Business Administration from the Vlerick School of Management, Belgium.
spacer
Jan Denecker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Avacta and Mologic Enter Research and Product Development Collaboration Agreement

Avacta announces the formation of a collaborative research partnership
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Medical Devices 2017

27-28 June 2017, Santa Clara, CA

OCT Medical Devices moved to Irvine, California for the first year in 2016, and we are pleased to say it proved a resounding success. As the only event to cater for the Southern California Medical device hub in Irvine, it brought together a variety of medical device companies of all sizes, including Medtronic, Edwards Lifesciences, Onciomed, Inc and St Jude Medical.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement